Merck appoints Clara Sattler de Sousa e Brito and Robert Machinek to key leadership roles
Clara Sattler de Sousa e Brito to lead discovery solutions from Q3 2026, while Robert Machinek takes over as Head of Strategy & Business Development
Clara Sattler de Sousa e Brito to lead discovery solutions from Q3 2026, while Robert Machinek takes over as Head of Strategy & Business Development
Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California
The company said data from multiple VESPER studies show the peptide delivered meaningful weight loss, favorable tolerability, and the possibility of a first-in-class monthly injection format
At 34 weeks, Ultomiris achieved a 43.4% placebo-adjusted reduction in 24-hour urine protein creatinine ratio (UPCR) versus placebo, meeting the study’s key interim endpoint
First installation of AI-powered AMULET SOPHINITY at NM Medical aims to strengthen early breast cancer detection
Dengue, a mosquito-borne viral disease, is emerging as a growing public health threat across Africa
The company will present 21 oral and poster presentations spanning investigational and approved therapies
The campaign places renewed focus on a disease that remains incurable despite major scientific advances
We are building the bridge between complex molecular data and everyday clinical decisions
Subscribe To Our Newsletter & Stay Updated